[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334688-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334688-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ythdf2-protein-stabilization-by-the-deubiquitinase-otub1-promotes-prostate-cancer-cell-proliferation-via-prss8-mrna-degradation","YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation","","Prostate cancer relies on dysregulated RNA methylation pathways, where m6A on mRNA influences splicing, turnover, transport, and translation through reader proteins such as YTHDF2. This study identifies the deubiquitinase OTUB1 as a stabilizer of YTHDF2 by suppressing its ubiquitination. Ubiquitination assays show OTUB1 blocks ubiquitin transfer to YTHDF2 independently of deubiquitinase activity. Transcriptomic and m6A-sequencing analyses highlight PRSS8 as a tumor suppressor target downregulated at both mRNA and protein levels. Mechanistically, YTHDF2 binds PRSS8 mRNA and promotes its degradation in an m6A-dependent manner.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ythdf2-protein-stabilization-by-the-deubiquitinase-otub1-promotes-prostate-cancer-cell-proliferation-via-prss8-mrna-degradation/334688/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ythdf2-protein-stabilization-by-the-deubiquitinase-otub1-promotes-prostate-cancer-cell-proliferation-via-prss8-mrna-degradation/334688.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does OTUB1 affect YTHDF2 protein stability?","Question",{"text":63,"@type":64},"OTUB1 increases YTHDF2 protein stability by inhibiting YTHDF2 ubiquitination, blocking ubiquitin transfer to YTHDF2 independently of OTUB1 deubiquitinase activity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does PRSS8 play in the OTUB1–YTHDF2 pathway?",{"text":68,"@type":64},"PRSS8 is identified as a potential tumor suppressor gene whose mRNA and protein levels decrease upon OTUB1 and YTHDF2 action in prostate cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"How does YTHDF2 regulate PRSS8 expression mechanistically?",{"text":72,"@type":64},"YTHDF2 binds PRSS8 mRNA and promotes its degradation in an m6A-dependent manner, linking m6A reader function to PRSS8 suppression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334688,1790496312,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE  \nYTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation  \nReceived for publication, September 22, 2023, and in revised form, February 23, 2024 Published, Papers in Press, March 9, 2024, [https://doi.org/10.1016/j.jbc.2024.107152](https://doi.org/10.1016/j.jbc.2024.107152)  \nXuefeng Zhao 1, Suli Lv 1, Neng Li 1, Qingli Zou 1, Lidong Sun 1,2, *, and Tanjing Song 1,2, *  \nFrom the 1Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2Cell Architecture Research Institute, Huazhong University of Science and Technology, Wuhan, Hubei, China  \nReviewed by members of the JBC Editorial Board. Edited by Brian Strahl  \nProstate cancer is a leading cause of cancer-related mortality in males. Dysregulation of RNA adenine N-6 methylation (m6A) contributes to cancer malignancy. m6A on mRNA may affect mRNA splicing, turnover, transportation, and translation. m6A exerts these effects, at least partly, through dedicated m6A reader proteins, including YTH domain–containing family protein 2 (YTHDF2). YTHDF2 is necessary for development while its dysregulation is seen in various cancers, including prostate cancer. However, the mechanism underlying the dysregulation and function of YTHDF2 in cancer remains elusive. Here, we ﬁnd that the deubiquitinase OUT domain– containing ubiquitin aldehyde-binding protein 1 (OTUB1) increases YTHDF2 protein stability by inhibiting its ubiquitination. With in vivo and in vitro ubiquitination assays, OTUB1 is shown to block ubiquitin transfer to YTHDF2 independent of its deubiquitinase activity. Furthermore, analysis of functional transcriptomic data and m6A-sequencing data identiﬁes PRSS8 as a potential tumor suppressor gene. OTUB1 and YTHDF2 decrease mRNA and protein levels of PRSS8, which is a trypsinlike serine protease. Mechanistically, YTHDF2 binds PRSS8 mRNA and promotes its degradation in an m6A-dependent manner. Further functional study on cellular and mouse models reveals PRSS8 is a critical downstream effector of the OTUB1–YTHDF2 axis in prostate cancer. We ﬁnd in prostate cancer cells, PRSS8 decreases nuclear β-catenin level through E-cadherin, which is independent of its protease activity. Collectively, our study uncovers a key regulator of YTHDF2 protein stability and establishes a functional OTUB1– YTHDF2–PRSS8 axis in prostate cancer.  \nProstate cancer presents a major challenge for male health and survival. Despite the prevailing antiandrogen therapy, the disease eventually acquires androgen independency and progresses to metastasis (1). Each year, prostate cancer causes more than 300,000 deaths worldwide (2). Uncovering novel protumor pathways in prostate cancer hold promise for unmet medical needs (3). Methylation of adenine N6 (m6A) is a  \n* For correspondence: Lidong Sun, [LidongSun@hust.edu.cn](LidongSun@hust.edu.cn); Tanjing Song, [SongT@hust.edu.cn](SongT@hust.edu.cn).  \nwidespread modiﬁcation on mRNA and noncoding RNA (4). m6A has gained extensive attention in the past decade. Like the case for histone modiﬁcations, m6A also has its writers, readers, and erasers (5). m6A is mainly catalyzed by a methyltransferase complex, the \"writer,\" which consists of the catalytic METTL3 and other subunits including METTL14 (5, 6), while METTL3 alone is catalytically incompetent. Consistently, in vitro and in vivo studies have shown that the integrity of the complex is critical for m6A installation (7, 8). Conversely, m6A can be removed by demethylase fat mass and obesity (FTO)-associated protein or ALKBH5, the “eraser” (5). m6A impacts essentially every aspect of RNA biology, including conformation, splicing, transportation, translation, and turnover of RNA (4). These pleiotropic effects can be mediated by a group of proteins recognizing the modiﬁcation, including YTH domain–containing family proteins YTHDF1","cbCaif9cbnrFpcui","https://ap.wps.com/l/cbCaif9cbnrFpcui","pdf",2966240,18,"English","# YTHDF2, m6A signaling, and prostate cancer context\n## OTUB1 increases YTHDF2 protein stability by inhibiting ubiquitination\n## PRSS8 identification and suppression downstream of the OTUB1–YTHDF2 axis\n## YTHDF2-mediated, m6A-dependent PRSS8 mRNA degradation\n## Functional effects on β-catenin and cellular/mouse models","[{\"question\":\"How does OTUB1 affect YTHDF2 protein stability?\",\"answer\":\"OTUB1 increases YTHDF2 protein stability by inhibiting YTHDF2 ubiquitination, blocking ubiquitin transfer to YTHDF2 independently of OTUB1 deubiquitinase activity.\"},{\"question\":\"What role does PRSS8 play in the OTUB1–YTHDF2 pathway?\",\"answer\":\"PRSS8 is identified as a potential tumor suppressor gene whose mRNA and protein levels decrease upon OTUB1 and YTHDF2 action in prostate cancer.\"},{\"question\":\"How does YTHDF2 regulate PRSS8 expression mechanistically?\",\"answer\":\"YTHDF2 binds PRSS8 mRNA and promotes its degradation in an m6A-dependent manner, linking m6A reader function to PRSS8 suppression.\"}]","YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation | PDF",1790007872,45]